Clinical Trial Update: n-3 and n-6 Fatty Acids in Rheumatoid Arthritis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating omega-3 and omega-6 fatty acids in rheumatoid arthritis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Omega-3 and Omega-6 fatty acids (polyunsaturated fatty acids (n-3 and n-6))

Snippet

Sponsor: Charite University, Berlin, Germany | Conditions: Rheumatoid Arthritis | Phase 2 | Status: COMPLETED